Pay in 4 interest-free payments of $5.52 Learn more
Ships within 48 hours · Estimated delivery Nov 2 - Nov 7
Its GLP-1 activity reduces blood glucose levels, creating an environment that restores GIPR sensitivity [24]
The workaround many prescribers use: if a non-diabetic patient also has a comorbidity that a GLP-1 drug treats (cardiovascular disease for Wegovy, sleep apnea for Zepbound), the prescriber can request coverage under that indication
Start with one method and add the second only after establishing tolerance
The escalation length
While the drug has proven effective for these purposes, concerns have emerged regarding its side effects
US$ 28.14
US$ 27.06
US$ 27.00
US$ 23.98
US$ 28.14
US$ 27.62
